Close

Rhythm Pharmaceuticals to Report Second Quarter 2023 Financial Results on Tuesday, August 1, 2023 Jul 17, 2023 06:00AM
Canaccord Genuity Assumes Rhythm Pharmaceuticals (RYTM) at Buy Jan 18, 2023 07:14AM
Rhythm Pharmaceuticals to Present at Canaccord Genuity 42nd Annual Growth Conference Aug 3, 2022 08:00AM
Rhythm Pharmaceuticals to Present at Canaccord Genuity 42nd Annual Growth Conference Aug 3, 2022 08:00AM
Rhythm Pharmaceuticals to Present at 2021 Canaccord Genuity 41st Annual Growth Conference Aug 5, 2021 08:00AM


Aug 5, 2021 08:00AM Rhythm Pharmaceuticals to Present at 2021 Canaccord Genuity 41st Annual Growth Conference
Feb 10, 2021 05:23PM Rhythm Pharmaceuticals, Inc. Announces Closing of $172.5 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Feb 10, 2021 05:23PM Rhythm Pharmaceuticals, Inc. Announces Closing of $172.5 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Feb 5, 2021 06:12AM Rhythm Pharmaceuticals (RYTM) Prices 5M Share Common Offering at $30/Sh
Feb 4, 2021 09:49PM Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering
Feb 4, 2021 09:49PM Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering
Aug 6, 2020 08:00AM Rhythm Pharmaceuticals to Present Virtually at Canaccord Genuity 40th Annual Growth Conference
Aug 6, 2020 08:00AM Rhythm Pharmaceuticals to Present Virtually at Canaccord Genuity 40th Annual Growth Conference
Jul 8, 2019 07:01AM UPDATE: Canaccord Genuity Starts Rhythm Pharmaceuticals (RYTM) at Buy